免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Imbio 分段编辑工具软件

K号: K180129 · 2018-03-16

申请人Imbio, LLC
决定日期2018-03-16
产品代码LLZ
咨询委员会RA
决定实质等同

器械摘要

Imbio Segmentation Editing Tool software is the device name listed in this FDA 510(k) record. The listed applicant is Imbio, LLC. It received FDA 510(k) clearance on 2018-03-16 under 510(k) number K180129. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Imbio Segmentation Editing Tool software?

Imbio Segmentation Editing Tool software is a medical device that received FDA 510(k) clearance on 2018-03-16. The listed applicant is Imbio, LLC. The 510(k) number is K180129.

When did Imbio Segmentation Editing Tool software receive FDA 510(k) clearance?

Imbio Segmentation Editing Tool software received FDA 510(k) clearance on 2018-03-16, under 510(k) number K180129.

Who is the listed applicant for Imbio Segmentation Editing Tool software?

The FDA 510(k) record lists Imbio, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Imbio Segmentation Editing Tool software?

The FDA product code for Imbio Segmentation Editing Tool software is LLZ.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Imbio, LLC为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:LLZ)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑